Shu, S., Lin, C. Y., He, H. H., Witwicki, R. M., Tabassum, D. P., Roberts, J. M., . . . Polyak, K. (2016). Response and resistance to BET bromodomain inhibitors in triple negative breast cancer. Nature.
Chicago ZitierstilShu, Shaokun, et al. "Response and Resistance to BET Bromodomain Inhibitors in Triple Negative Breast Cancer." Nature 2016.
MLA ZitierstilShu, Shaokun, et al. "Response and Resistance to BET Bromodomain Inhibitors in Triple Negative Breast Cancer." Nature 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.